Editorial
 THE ANDA GALLOP   
 Wednesday, January 16, 2019 
 In spite of several headwinds including intermittent warning letters by the US FDA even to major Indian companies, the Indian pharmaceutical companies and their subsidiaries have shown an impressive performance 
  Past Editorial...  
TODAY'S NEWS
15:00  [IST]ISPE releases Good Practice Guide: Technology Transfer 3rd Edition
14:50  [IST]NetApp fosters innovation among healthcare startups Praktice.ai and Cardiotrack to fine-tune their products
14:00  [IST]DKSH to distribute Novo Nordisk's pharmaceutical grade compounds in 11 markets in Asia Pacific
13:00  [IST]CBMG gets Chinese approval to start phase II trial of stem cell drug AlloJoin therapy for knee osteoarthritis
12:00  [IST]Diagnomics introduces ACMG 59 report for personalized genetic testing
11:00  [IST]Philips introduces Azurion with FlexArm for clinician to perform imaging across whole patient in both 2D and 3D
more news >>
TOP NEWS
08:00  [IST]Banks' refusal to issue e-BRC hurt export shipments of pharma SMEs
08:00  [IST]Parliamentary panel reviewing new AHP Bill set to seek stakeholders’ suggestions
08:00  [IST]MSF, Lawyers Collective seek removal of Rule 3(f) from draft Patents Amendment Rules 2018
08:00  [IST]Kerala govt withdraws 2013 order mandating clinical trials for ayurvedic proprietary drugs, permits pilot study for licences
08:00  [IST]US FDA issues guidance for clinical trial endpoints for approval of cancer drugs and biologics
08:00  [IST]Gujarat based companies propose big ticket investments worth Rs.8,223 crore through 273 MoUs
more news >>
YESTERDAY'S NEWS
18:00  [IST]Therachon gets US FDA orphan drug status for apraglutide for short bowel syndrome treatment
17:00  [IST]Pacira Pharma phase 4 study of Exparel in patients undergoing C-section achieves primary endpoint with significant reductions in opioid consumption
16:00  [IST]Targovax gets European patent for mutant-RAS neoantigen & mutant-RAS specific T cells
15:00  [IST]OKI, ARC Innovation Center at Sheba join forces to prevent dementia
12:40  [IST]Brains Hospital trains over 100 BMTC drivers & conductors in life-saving skills for Golden Hour
12:20  [IST]AffordPlan partners with 800 hospitals to expand presence across India registers high growth in maternity patient base
more news >>
INTERVIEW  
Rising burden of NCDs impacts Indian healthcare scene
Gagan Singh Bedi, managing director, AstraZeneca Pharma India Gagan-Singh-Bedi.jpg
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the central govt's decision to replace MCI with National Medical Commission boost the medical education scenario in the country?
  
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
Chemspec_india_2019
anticounter_Panel_2019
Pharma_Proj
BioAsia
cphi-india_Banner-150x60
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |